...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: I'm Bullish Again on RVX and ZENITH

Sarah has confirmed that both RVX and ZEN have consented to the webinar. :-)

Share
New Message
Please login to post a reply